|
CN105267194A
|
|
Composition and application of composition to anti-inflammatory drugs
|
|
CN105232513A
|
|
Composition and application thereof to antibacterial drugs
|
|
CN105267195A
|
|
Composition and application of composition to acute renal failure resisting drugs
|
|
CN105168216A
|
|
Composition 55092202050677 and application thereof in drug for preventing and treating liver injury
|
|
CN105343092A
|
|
Composition 34092202050675 and application thereof in anti-heart-failure drugs
|
|
CN105213395A
|
|
Compositions and the application in anti-acute renal failure medicine thereof
|
|
CN105250302A
|
|
Composition and application thereof in acute gout resisting drugs
|
|
CN105168217A
|
|
Composition 14091302050644 and application thereof in anti-hypoxic drug
|
|
CN105250301A
|
|
Composition 77092202050623 and application thereof in anti-hepatic fibrosis drugs
|
|
CN105213396A
|
|
Compositions and the application in anti-inflammatory drug thereof
|
|
CN104820048A
|
|
Optimizing method for gradient separation conditions of liquid chromatography
|
|
CN104844537A
|
|
Preparation method of important intermediate 2-cyano-6-methoxybenzothiazole of D-luciferin
|
|
CN104744426A
|
|
Structure, synthesis and use of 2-ethyle-2-allyloxymethyl-1,3-propylene carbonate
|
|
CN103879986A
|
|
Simple method for preparing large-aperture mesoporous carbon
|
|
CN103772347A
|
|
Method for preparing carbonic ester monomer containing glycol ether lateral group
|
|
CN103951567A
|
|
N-substituted phenyl-1,7,7-trimethyl bicyclo[2.2.1]heptan-2-amine production method
|
|
CN103752293A
|
|
Bis-(ureido)/ureido-carbamate liquid chromatography stationary phase and preparation method thereof
|
|
CN103752267A
|
|
Preparation method of carbon aerogel adsorbent for oil contamination treatment and prepared carbon aerogel adsorbent
|
|
CN103246536A
|
|
Method for wirelessly upgrading firmware of instrumented positioning system
|
|
CN103319440A
|
|
Diol bisepoxysuccinate diester, and preparation method and use thereof
|
